Showing results (61-70 of 76) with videos related to
Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
DNA repair pathway profiling and microsatellite instability in colorectal cancerJinsheng Yu, Mary A Mallon, Wanghai Zhang, et al.Human Molecular Genetics|October 22, 2005
Polymorphism discovery in 51 chemotherapy pathway genesRobert R Freimuth, Ming Xiao, Sharon Marsh, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: final reportGiancarlo A Pillot, William L Read, Kristin L Hennenfent, et al.The Journal of Rheumatology|April 3, 2008
Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritisPrabha Ranganathan, Robert Culverhouse, Sharon Marsh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Irinotecan pharmacogenetics: influence of pharmacodynamic genesJanelle M Hoskins, Eugenio Marcuello, Albert Altes, et al.Cancer Research|October 6, 2005
CpG island methylation of DNA damage response genes in advanced ovarian cancerJens M Teodoridis, Jacqueline Hall, Sharon Marsh, et al.European Journal of Clinical Pharmacology|April 4, 2007
Identification of NR1I2 genetic variation using resequencingCristi R King, Ming Xiao, Jinsheng Yu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxelAnja Henningsson, Sharon Marsh, Walter J Loos, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Hoosier Oncology Group randomized phase II study of docetaxel, vinorelbine, and estramustine in combination in hormone-refractory prostate cancer with pharmacogenetic survival analysisNoah M Hahn, Sharon Marsh, William Fisher, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapySharon E Johnatty, Jonathan Beesley, Jim Paul, et al.Pageof 8